ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,23%
Euro vs US Dollar
1,07202
0,02%
Bitcoin
57.339,13
-1,54%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV
  6. ImmunoPrecise Antibodies Ltd (IPA)

  7. ImmunoPrecise Antibodies Ltd (IPA) News

IPA

ImmunoPrecise Antibodies (IPA)

ImmunoPrecise Antibodies Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:IPA
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202215h18InvestorsHub NewsWireIPA's Subsidiary BioStrand Secures Second VLAIO Research GrantTSXV:IPAImmunoPrecise Antibodies Ltd
14/04/202214h06InvestorsHub NewsWireIPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and OfferingsTSXV:IPAImmunoPrecise Antibodies Ltd
29/03/202217h48InvestorsHub NewsWireIPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial IntelligenceTSXV:IPAImmunoPrecise Antibodies Ltd
14/03/202214h04InvestorsHub NewsWireIPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of DefenseTSXV:IPAImmunoPrecise Antibodies Ltd
09/03/202214h07InvestorsHub NewsWireIPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03TSXV:IPAImmunoPrecise Antibodies Ltd
08/04/202114h08InvestorsHub NewsWireImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's DiseaseTSXV:IPAImmunoPrecise Antibodies Ltd
13/02/202107h25PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:IPAImmunoPrecise Antibodies Ltd
23/12/202013h30PR Newswire (Canada)ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock ExchangeTSXV:IPAImmunoPrecise Antibodies Ltd
21/12/202014h12PR Newswire (Canada)ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal YearTSXV:IPAImmunoPrecise Antibodies Ltd
14/12/202013h20PR Newswire (Canada)ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine CandidateTSXV:IPAImmunoPrecise Antibodies Ltd
11/12/202013h45PR Newswire (Canada)ImmunoPrecise Collaboration Enables Preclinical Manufacturing of Lead Antibodies Targeting SARS-CoV-2TSXV:IPAImmunoPrecise Antibodies Ltd
25/11/202019h46PR Newswire (Canada)ImmunoPrecise Antibodies Ranked Number 240 Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500™TSXV:IPAImmunoPrecise Antibodies Ltd
23/11/202013h00PR Newswire (Canada)IPA Selects Polytope™ Formulations for Pre-Clinical StudiesTSXV:IPAImmunoPrecise Antibodies Ltd
19/11/202013h00PR Newswire (Canada)ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious DiseaseTSXV:IPAImmunoPrecise Antibodies Ltd
18/11/202002h01PR Newswire (Canada)ImmunoPrecise Antibodies Confirms Effective Date of Share ConsolidationTSXV:IPAImmunoPrecise Antibodies Ltd
09/11/202015h11PR Newswire (Canada)ImmunoPrecise Antibodies Files Preliminary Base Shelf Prospectus and Registration StatementTSXV:IPAImmunoPrecise Antibodies Ltd
05/11/202001h08PR Newswire (Canada)ImmunoPrecise Antibodies to Complete Share Consolidation in Preparation for Potential Nasdaq ListingTSXV:IPAImmunoPrecise Antibodies Ltd
03/11/202013h30PR Newswire (Canada)ImmunoPrecise Antibodies and Mila Announce Strategic AI PartnershipTSXV:IPAImmunoPrecise Antibodies Ltd
27/10/202012h28PR Newswire (Canada)ImmunoPrecise and Twist Bioscience Announce Collaboration for the Creation of Novel, Therapeutic ProductsTSXV:IPAImmunoPrecise Antibodies Ltd
08/10/202013h30PR Newswire (Canada)IPA Delivers Lead Candidate Antibodies from B Cell Select™ Platform for at Home SARS-CoV-2 Diagnostic TestTSXV:IPAImmunoPrecise Antibodies Ltd
06/10/202013h30PR Newswire (Canada)IPA's CEO Dr. Jennifer Bath to Appear Live Wednesday on BNN TelevisionTSXV:IPAImmunoPrecise Antibodies Ltd
05/10/202013h30PR Newswire (Canada)ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & FriendsTSXV:IPAImmunoPrecise Antibodies Ltd
29/09/202015h10PR Newswire (Canada)ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021TSXV:IPAImmunoPrecise Antibodies Ltd
28/09/202017h59PR Newswire (Canada)IPA CEO Dr. Jennifer Bath to Appear Live Today on Bloomberg TelevisionTSXV:IPAImmunoPrecise Antibodies Ltd
28/09/202013h30PR Newswire (Canada)ImmunoPrecise to Present at the Virtual Gravitas Healthcare Investor DayTSXV:IPAImmunoPrecise Antibodies Ltd
25/09/202013h30PR Newswire (Canada)ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical TrialsTSXV:IPAImmunoPrecise Antibodies Ltd
22/09/202013h30PR Newswire (Canada)IPA Europe Significantly Expands its Capabilities, Releasing its Second-Generation B Cell Select ™TSXV:IPAImmunoPrecise Antibodies Ltd
17/09/202013h30PR Newswire (Canada)ImmunoPrecise Announces New Multi-Specific SARS-CoV-2 Antibody Collaboration with ZymeworksTSXV:IPAImmunoPrecise Antibodies Ltd
10/09/202013h30PR Newswire (Canada)ImmunoPrecise Commences Application Process to Dual List on NASDAQTSXV:IPAImmunoPrecise Antibodies Ltd
09/09/202023h37PR Newswire (Canada)ImmunoPrecise Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 202...TSXV:IPAImmunoPrecise Antibodies Ltd
 Showing the most relevant articles for your search:TSXV:IPA

Kürzlich von Ihnen besucht

TG
BAYN
Bayer
FX
EURUSD
Euro vs US Dollar
DBI
SDXP
SDAX
NASDAQ
MSFT
Microsoft
TG
BAS
BASF
TG
DTE
Deutsche Telekom
USOTC
BASFY
BASF (QX)
CCOM
US500
US 500
NYSE
KO
Coca Cola
NYSE
MRK
Merck
TG
NOV
Novo Nordisk
TG
D7G
Nel ASA
COIN
ETHUSD
Ethereum
AMEX
SPY
SPDR S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten